Kari Alitalo Selected Research

Kari Alitalo Research Topics

Disease

79	Neoplasms (Cancer) 01/2022 - 04/2002
30	Inflammation (Inflammations) 01/2021 - 05/2002
27	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2002
16	Lymphedema (Milroy Disease) 01/2022 - 07/2002
14	Lymphatic Metastasis 01/2020 - 04/2002
10	Hyperplasia 01/2020 - 03/2004
10	Edema (Dropsy) 01/2020 - 09/2002
9	Carcinogenesis 01/2016 - 12/2004
8	Hypoxia (Hypoxemia) 01/2020 - 10/2004
7	Hypertrophy 01/2019 - 10/2008
7	Ischemia 11/2016 - 06/2003
7	Carcinoma (Carcinomatosis) 03/2013 - 02/2004
6	Adenoma (Adenomas) 01/2021 - 05/2008
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 02/2005
6	Melanoma (Melanoma, Malignant) 01/2017 - 08/2005
6	Cardiomegaly (Heart Hypertrophy) 11/2016 - 10/2008
6	Pathologic Neovascularization 01/2015 - 09/2008
5	Breast Neoplasms (Breast Cancer) 09/2020 - 04/2002
5	Atherosclerosis 09/2017 - 10/2003
5	Arteriosclerosis 03/2010 - 05/2002
4	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 05/2014
4	Vascular Remodeling 01/2017 - 09/2002
4	Obesity 11/2016 - 02/2015
4	Wounds and Injuries (Trauma) 07/2008 - 07/2002
3	Insulin Resistance 12/2021 - 02/2015
3	Heart Failure 11/2016 - 12/2012
3	Pathologic Processes 11/2015 - 08/2004
3	Hypertension (High Blood Pressure) 07/2013 - 10/2008
3	Ovarian Neoplasms (Ovarian Cancer) 03/2013 - 02/2008
3	Infections 02/2011 - 02/2005
3	Hemorrhage 01/2011 - 09/2006
2	Lung Injury 01/2022 - 08/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 11/2002
2	Infarction (Infarctions) 01/2020 - 09/2008
2	Glioma (Gliomas) 12/2017 - 07/2003
2	Chylothorax 09/2017 - 02/2014
2	Weight Gain 11/2016 - 02/2015
2	Adenocarcinoma 01/2016 - 10/2010
2	Glaucoma 09/2014 - 09/2014
2	Hemangioma (Angioma) 01/2013 - 01/2013
2	Rheumatoid Arthritis 05/2011 - 01/2002

Drug/Important Bio-Agent (IBA)

65	Vascular Endothelial Growth Factor CIBA 01/2022 - 01/2002
56	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 03/2002
38	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2022 - 03/2002
25	Vascular Endothelial Growth Factor DIBA 01/2016 - 01/2002
18	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 05/2002
17	LigandsIBA 11/2021 - 04/2002
15	Vascular Endothelial Growth Factor BIBA 01/2021 - 02/2005
13	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022 - 06/2002
10	CytokinesIBA 01/2021 - 03/2002
9	Angiopoietin-2IBA 01/2021 - 09/2002
9	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2015 - 10/2003
8	AngiopoietinsIBA 01/2022 - 05/2010
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2004
8	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2020 - 04/2002
8	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2015 - 09/2002
8	Phosphotransferases (Kinase)IBA 10/2015 - 09/2003
7	Transcription Factors (Transcription Factor)IBA 10/2018 - 03/2005
6	AntibodiesIBA 01/2022 - 04/2002
6	Messenger RNA (mRNA)IBA 01/2020 - 01/2002
5	Blocking AntibodiesIBA 01/2021 - 09/2010
5	EnzymesIBA 09/2020 - 04/2002
5	Vascular Endothelial Growth FactorsIBA 01/2020 - 09/2002
5	CollagenIBA 05/2015 - 06/2003
5	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2011 - 03/2002
4	TIE Receptors (TIE Receptor Tyrosine Kinases)IBA 01/2022 - 05/2010
4	CateninsIBA 01/2022 - 05/2014
4	TIE-2 Receptor (Receptor, TIE 2)IBA 01/2020 - 09/2002
4	Therapeutic UsesIBA 10/2015 - 01/2005
4	Angiopoietin-1IBA 06/2009 - 03/2003
4	Collagen Type XVIII (Type XVIII Collagen)IBA 12/2007 - 10/2002
4	EndostatinsIBA 12/2007 - 10/2002
3	Insulin (Novolin)FDA Link 12/2021 - 10/2006
3	IntegrinsIBA 01/2020 - 01/2012
3	Keratin-14 (Keratin 14)IBA 11/2016 - 05/2009
3	LipidsIBA 04/2016 - 03/2010
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2015 - 03/2002
3	Biological ProductsIBA 04/2011 - 08/2004
2	AntigensIBA 01/2020 - 05/2009
2	Bevacizumab (Avastin)FDA Link 07/2019 - 11/2012
2	Doxycycline (Periostat)FDA LinkGeneric 09/2017 - 02/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2016 - 02/2005
2	CarcinogensIBA 01/2016 - 12/2007
2	Tyrosine Kinase InhibitorsIBA 10/2015 - 06/2008
2	Angiotensin IIIBA 10/2015 - 10/2008
2	Annexin A1IBA 09/2015 - 09/2014
2	Indicators and Reagents (Reagents)IBA 05/2015 - 08/2005
2	Membrane Proteins (Integral Membrane Proteins)IBA 05/2015 - 03/2005
2	LDL Receptors (LDL Receptor)IBA 06/2014 - 08/2005
2	Lipoproteins (Lipoprotein)IBA 06/2014 - 08/2005
2	Apolipoprotein B-48IBA 06/2014 - 08/2005
2	Placenta Growth FactorIBA 08/2013 - 10/2010
2	SaltsIBA 07/2013 - 05/2009
2	Pharmaceutical PreparationsIBA 08/2012 - 05/2010
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2012 - 10/2010
2	tyrosine receptor (receptor, tyrosine)IBA 01/2012 - 09/2003

Therapy/Procedure

27	Therapeutics 01/2021 - 06/2002
7	Drug Therapy (Chemotherapy) 12/2017 - 03/2002
4	Radiotherapy 09/2020 - 12/2007
2	Immunotherapy 01/2020 - 01/2016